Registration - Amendment
OGR for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
Firm
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General prescription drug affordability and access. Provisions related to Part D access and drug pricing negotiation; Compulsory licensing policy issues; H.R.1046, Medicare Negotiation and Competitive Licensing Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN New | Sr. Advisor/ Director Member Services/ Floor Asst, Rep. Pelosi; Director Intergovt Affairs/ COS Cong. Affairs/ Special Asst, Labor Dept; LA, Rep. Sandlin |
| KARISSA WILLHITE New | Dep. Chief of Staff, Sen. Menendez; Dep. Exec Director/ Policy Director, House Democratic Caucus; Sr. LA, Rep. Menendez |
Medicare/Medicaid MMM
General prescription drug affordability and access. Provisions related to Part D access and drug pricing negotiation; Compulsory licensing policy issues; H.R.1046, Medicare Negotiation and Competitive Licensing Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN New | Sr. Advisor/ Director Member Services/ Floor Asst, Rep. Pelosi; Director Intergovt Affairs/ COS Cong. Affairs/ Special Asst, Labor Dept; LA, Rep. Sandlin |
| KARISSA WILLHITE New | Dep. Chief of Staff, Sen. Menendez; Dep. Exec Director/ Policy Director, House Democratic Caucus; Sr. LA, Rep. Menendez |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.